Moderna's Omicron-Specific COVID-19 Booster to be Trialled in the UK
The phase 3 trial will involve 3000 participants across 29 centres.
United Kingdom Catherine Cosgrove Sajid Javid Lucy Chappell National Institute For Health Research University Of London
Source: medscape.com